Ember Therapeutics, Inc. (EMBT)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2014 | 200.43 Thousand USD | 9.1% |
| 2013 | 183.71 Thousand USD | 14.02% |
| 2012 | 161.12 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2015 Q3 | 212.31 Thousand USD | 2.92% |
| 2015 Q1 | 204.77 Thousand USD | 2.17% |
| 2015 Q2 | 206.29 Thousand USD | 0.74% |
| 2014 Q2 | 194.71 Thousand USD | 5.36% |
| 2014 Q1 | 184.8 Thousand USD | 0.6% |
| 2014 Q3 | 197.28 Thousand USD | 1.32% |
| 2014 FY | 200.43 Thousand USD | 9.1% |
| 2014 Q4 | 200.43 Thousand USD | 1.6% |
| 2013 Q4 | 183.71 Thousand USD | 0.0% |
| 2013 FY | 183.71 Thousand USD | 14.02% |
| 2012 FY | 161.12 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1310.00 USD | 15400.153% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 96.452% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 99.532% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | 180.295% |
| Rebus Holdings, Inc. | 305 Thousand USD | 34.285% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 103.179% |
| Qrons Inc. | 351.42 Thousand USD | 42.966% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 622.36 Thousand USD | 67.795% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 99.539% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | 1082.125% |
| Skye Bioscience, Inc. | -5.72 Million USD | 103.503% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 98.728% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 95.133% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | 50.123% |
| SQZ Biotechnologies Company | -36.23 Million USD | 100.553% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | 91.061% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | 78.383% |
| Mesoblast Limited | 55.85 Million USD | 99.641% |
| Marizyme, Inc. | 18.56 Million USD | 98.921% |
| Genus plc | 190.6 Million USD | 99.895% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | 91.035% |
| Pharming Group N.V. | 109.8 Million USD | 99.817% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | 76.7% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | 83.488% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | 70.525% |
| ContraFect Corporation | -6.02 Million USD | 103.326% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | -48.866% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | 82.653% |
| IMV Inc. | 7.67 Million USD | 97.387% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 96.357% |
| MultiCell Technologies, Inc. | 90.04 USD | -222503.287% |
| ONE Bio Corp. | 9.04 Million USD | 97.783% |
| Accustem Sciences Inc. | -733.97 Thousand USD | 127.308% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 98.452% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.36 Million USD | 85.348% |
| Q BioMed Inc. | 4.06 Million USD | 95.063% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 99.344% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | 80.11% |
| Biomind Labs Inc. | 711.4 Thousand USD | 71.826% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 99.669% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | 89.975% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 98.435% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | 44.28% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | -43.366% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | -908.869% |
| Curative Biotechnology, Inc. | 2.2 Million USD | 90.898% |
| GB Sciences, Inc. | 1.74 Million USD | 88.529% |
| Alpha Cognition Inc. | -183.78 Thousand USD | 209.056% |
| HST Global, Inc. | 96.79 Thousand USD | -107.073% |
| CSL Limited | 10.52 Billion USD | 99.998% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | 2.805% |
| Halberd Corporation | 144.72 Thousand USD | -38.495% |
| Enzolytics Inc. | 981.65 Thousand USD | 79.582% |
| Agentix Corp. | 37.63 Thousand USD | -432.625% |
| Resverlogix Corp. | 6.45 Million USD | 96.893% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | 129.778% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | -2.02 Billion USD | 100.01% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 100.426% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 97.165% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 92.6% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 102.267% |
| AVAX Technologies, Inc. | -5.9 Million USD | 103.395% |
| Zenith Capital Corp. | 10.06 Thousand USD | -1891.574% |
| Genscript Biotech Corporation | -1.06 Billion USD | 100.019% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | 91.6% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | -21.836% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | 1194.181% |
| Kadimastem Ltd | -253.1 Thousand USD | 179.19% |
| Helix BioMedix, Inc. | -2.57 Million USD | 107.799% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 99.011% |
| BioStem Technologies, Inc. | 4.47 Million USD | 95.518% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | 0.408% |
| LadRx Corporation | -2.03 Million USD | 109.842% |
| Cell Source, Inc. | 9.23 Million USD | 97.829% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 68.444% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 68.444% |
| NovAccess Global Inc. | 2.17 Million USD | 90.799% |
| Affymax, Inc. | -5.59 Million USD | 103.581% |
| Itoco Inc. | 228.3 Thousand USD | 12.209% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | -47.388% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 95.957% |
| Mobile Lads Corp. | 484.23 Thousand USD | 58.608% |
| CytoDyn Inc. | 20.26 Million USD | 99.011% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | 31078.671% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | 2262.545% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 97.399% |
| SYBLEU INC | 473.71 Thousand USD | 57.689% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 95.503% |
| International Stem Cell Corporation | 2.59 Million USD | 92.261% |
| Bioxytran, Inc. | 1.89 Million USD | 89.445% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -221.138% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 90.81% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 94.163% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 97.657% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 772.6 Thousand USD | 74.058% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | 116.035% |
| Neutra Corp. | 52.18 Thousand USD | -284.065% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | 108.053% |
| PureTech Health plc | -167.19 Million USD | 100.12% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | 181.84% |
| IXICO plc | -4.44 Million USD | 104.51% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 98.484% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 99.635% |
| CSL Limited | 10.52 Billion USD | 99.998% |
| Cellectis S.A. | -43.81 Million USD | 100.457% |